EUVIMEDEUVIMED entdecken
Crossref

A new platform of electrowetting-on-dielectric digital microfluidics for rapid detection of early-stage Hepatocellular Carcinoma(HCC) specific biomarker

Wenjie Zhu, Hong Qian, Shengya Cao, Wei Xia, Xilong Wang, Jing Jin, Xin Wang, Hao Zhang, Dongsheng Liu, Ying Chen

Analytica Chimica Acta · 2025

DOI: 10.1016/j.aca.2024.343533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2025. Verfasst von Wenjie Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Technology, Xuzhou Medical University, Xuzhou, 221004, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Biomarkers, Tumor, alpha-Fetoproteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The early detection of Hepatocellular Carcinoma (HCC) is crucial for improving patient survival rates.Early diagnosis of HCC can significantly enhance treatment outcomes and reduce disease progression. Antigen detection of tumor markers is one of the important diagnostic methods for HCC. However, Traditional antigen detection methods often rely on heavy detection equipment, involve lengthy turnaround times, and must be conducted in laboratory settings. Therefore, there is a clear need for a portable, low-skill, rapid sample-to-result detection method for early HCC biomarkers. RESULTS: We propose a new platform based on electrowetting-on-dielectric digital microfluidic(EWOD-DMF) for the detection of early-stage HCC biomarkers, enabling the quantitative measurement of Alpha-Fetoprotein (AFP), the proportion of AFP-L3 in total AFP (AFP-L3%), and Des-Gamma-Carboxy Prothrombin (DCP). First, serum samples are processed through the microfluidic system, achieving the separation of AFP-L3 within 10 min. Next, immunoassays are performed within 15 min, using magnetic particles to capture biomarkers such as AFP, AFP-L3, and DCP, followed by enzymatic reactions that generate detectable signals. Each chip can simultaneously detect three biomarkers from five different samples, allowing for a total of fifteen targets to be tested, with only approximately 2.4 μL of serum required for each biomarker detection. Ultimately, data are analyzed with dedicated software to quantitatively measure the HCC biomarkers. The detection limits for AFP or AFP-L3 and for DCP are 0.24 ng/mL and 1.89 ng/mL, respectively. SIGNIFICANCE: This study presents a EWOD-DMF platform for early-stage HCC diagnosis, capable of simultaneously detecting multiple samples and biomarkers, thus improving detection efficiency and diagnostic accuracy. Moreover, the platform has POCT capability, with advantages in portability and cost-effectiveness, providing clinicians and primary healthcare institutions with a fast and convenient solution for early-stage HCC diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBiomarkers, Tumoralpha-FetoproteinsHumansElectrowettingMicrofluidic Analytical TechniquesProthrombinEarly Detection of CancerProtein PrecursorsLab-On-A-Chip DevicesImmunoassayBiomarkers

Stichwörter der Autor:innen

Automated operationDigital microfluidicsHepatocellular carcinomaMultiple biomarkers detectionRapid

Substanzen

Biomarkers, Tumoralpha-FetoproteinsProthrombinacarboxyprothrombinProtein PrecursorsBiomarkers

Autor:innen und Institutionen

  • School of Medical Technology, Xuzhou Medical University, Xuzhou, 221004, China.
  • School of Medical Technology, Xuzhou Medical University, Xuzhou, 221004, China; Department of Laboratory Medicine, The Affiliated Suqian Hospital of Xuzhou Medical University, Suqian, 223800, China.
  • Department of Clinical Laboratory, Xuzhou Cancer Hospital, Xuzhou, 221004, China.
  • Nanjing RealMind Biotech Co., Ltd., Nanjing, 210046, China.
  • Department of Molecular Diagnostics, Roche Diagnostics (Shanghai) Limited Company, Shanghai, 200131, China.
  • Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, 221004, China; Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221000, China.

Zitieren

APA

Zhu, W., Qian, H., Cao, S., Xia, W., Wang, X., Jin, J., Wang, X., Zhang, H., Liu, D., & Chen, Y. (2025). A new platform of electrowetting-on-dielectric digital microfluidics for rapid detection of early-stage Hepatocellular Carcinoma(HCC) specific biomarker. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2024.343533

Vancouver

Zhu W, Qian H, Cao S, Xia W, Wang X, Jin J, et al. A new platform of electrowetting-on-dielectric digital microfluidics for rapid detection of early-stage Hepatocellular Carcinoma(HCC) specific biomarker. Analytica Chimica Acta. 2025. doi:10.1016/j.aca.2024.343533

BibTeX
@article{Zhu2025,
  author = {Zhu, Wenjie and Qian, Hong and Cao, Shengya and Xia, Wei and Wang, Xilong and Jin, Jing and Wang, Xin and Zhang, Hao and Liu, Dongsheng and Chen, Ying},
  title = {A new platform of electrowetting-on-dielectric digital microfluidics for rapid detection of early-stage Hepatocellular Carcinoma(HCC) specific biomarker},
  journal = {Analytica Chimica Acta},
  year = {2025},
  doi = {10.1016/j.aca.2024.343533}
}
Kostenlos starten →